ArticleInternational journal of oncology2019

Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.

Lu Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.